Kappa Delta Awards/OREF Clinical Research Awards
The American Academy of Orthopaedic Surgeons is soliciting manuscripts for the 2017 Kappa Delta Awards and the Orthopaedic Research and Education Foundation (OREF) Clinical Research Award. Up to two $20,000 Kappa Delta awards (Elizabeth Winston Lanier Award and Ann Doner Vaughan Award), one $20,000 Kappa Delta Young Investigator award, and one $20,000 OREF award will be bestowed, provided manuscripts of requisite quality are submitted.
Manuscripts should represent a large body of cohesive scientific work generally reflecting years of investigation. If the submission reflects a single project, it should be of high significance and impact. Manuscripts must be submitted by members (or candidate members) of the AAOS, ORS, Canadian Orthopaedic Association (COA), or Canadian Orthopaedic Research Society (CORS).
Please Note: Submissions failing to follow the below guidelines or instructions may not be considered.
For All Research Awards:
Manuscripts must be original and written specifically for this award.
Authors should identify the award for which their manuscript is considered most appropriate on the first page of the application (see template).
Authors should indicate if the manuscript has been submitted previously, and, if any of the authors have previously won a Kappa Delta Award. Preference will be given to those researchers who have not previously won the award.
For the Kappa Delta and Kappa Delta Young Investigator Awards:
Manuscripts should focus on the results of the author's basic and/or clinical research that relates to the musculoskeletal system.
The principal investigator submitting a manuscript for the Kappa Delta Young Investigator Award must be under 40 years of age or no more than seven years beyond training. The cover page should indicate the eligibility (statement of age or year training completed).
Investigators submitting a manuscript for the Kappa Delta Young Investigator Award must include a letter of support from the laboratory director or department chair.
For the OREF Clinical Research Award:
Manuscripts must involve clinical research related directly to musculoskeletal disease or injury.
Basic science studies that involve human tissues will not be considered in this category.
Instructions for All Award Submissions
- Manuscript (not to exceed 30 pages):
- Title Page: The title/cover page template must be completed in its entirety and included in the final PDF document (download the template - Microsoft Word format).
- Table of Contents: Include a table of contents with page numbers. This should be located after the title page and list the manuscript (30 pages including photos/charts/graphs/tables and references) and individual supporting documents (see below). Each section must be clearly labeled. The Table of Contents does not count toward the 30 page manuscript limit.
- Format: 12-point font, double spaced, one inch margins, numbered pages. Should be created in Microsoft Word of similar program on standard 8.5" x 11" pages and saved in PDF format.
- Photos/Charts/Graphs/Tables: All images should be embedded in the document.
- References: References should follow the format required by the Journal of Orthopaedic Research.
- Length: Not to exceed 30 pages (including photos, charts, graphs, tables, and references.). Documents that are requested in support of the application (Title page, summary of clinical relevance, disclosure statements of funding, summary of investigator's work leading to submitted document, description of all authors' roles in project, and author CVs) are not included in this 30 page limit. Any additional addenda will NOT be reviewed.
- DO NOT include nominations for the award, letters of support, explanations of the data, or any other nonspecified materials.
- Supporting Documents:
Documents must be clearly labeled and listed in the Table of Contents (Supporting documents are not included in the 30 page manuscript limit):
- Summary of clinical relevance.
- A brief summary of the investigator's work leading to the submitted document should be provided for manuscripts representing a comprehensive body of work.
- A brief description of the investigator's role in the project on which the paper is based should be provided. For papers with multiple authors, a description of each author's role in the project is required.
- Disclosure statements of funding and any potential conflicts of interest.
- Separate CVs for each author should be included. The NIH short CV Form (NEW - 5 page limit - download biosketch template), including a relevant bibliography should be used. Authors must be limited to those who have made a significant scientific contribution to the manuscript. Instructions and sample are available at http://grants.nih.gov/grants/funding/424/SF424R-R_biosketchsample_VerC.docx.
Submissions for the 2017 Kappa Delta and OREF Clinical Research Awards will be accepted in electronic format only. Please email a PDF of your entire submission to email@example.com no later than 11:59 PM CDT on July 1, 2016. Late submissions will not be considered.
PLEASE NOTE: The 2017 Kappa Delta and OREF Clinical Research Award winners will receive their award at the 2017 AAOS Annual Meeting (San Diego, CA, on March 14-18, 2017) and present their paper during the 2017 ORS Annual Meeting (San Diego, CA, March 19-23, 2017). If you have any questions, please contact Erin L. Ransford, Manager of Research Advocacy at +1 (847) 384-4319, or via email at
Award recipients (only the principal investigator) will be contacted personally if they are selected. An official award notification letter, copied to all authors, will follow. Individuals who have not been selected will also receive written confirmation of the final decisions.
Lastly, winners of Kappa Delta and OREF awards will be invited to submit a manuscript to the Journal of Orthopaedic Research (JOR), the official journal of the ORS, based on the work cited in the award, in the form of either a research paper or a review article, to be considered for publication, contingent upon satisfactory scientific review.
Submissions failing to follow the above guidelines or instructions may not be considered.